Psychiatry

Top Medical News
Visual impairment tied to heightened risk of suicidal tendencies among teens
14 hours ago
People with visual impairment may have increased suicidal tendencies, and this association is especially pronounced among adolescents, according to the results of a systematic review and meta-analysis.
Psychosocial risks may impair child’s development
Stephen Padilla, 20 hours ago
Adverse childhood experiences (ACEs), financial needs, and other maternal psychosocial hardships can negatively affect the development of children from vulnerable families in Singapore, according to a study.
People with depression gain most CV benefits from physical activity
2 days ago
Individuals who engage in physical activities (PA) enjoy a reduced risk of cardiovascular disease (CVD), especially those suffering from depression, with a recent study showing that PA acts through the brain’s stress-related activity.
Gestational Diabetes Mellitus
Kanas Chan, 16 Apr 2024

Gestational diabetes mellitus (GDM) is not associated with attention-deficit/hyperactivity disorder (ADHD) in offspring, a 20-year multinational study has shown.

Concomitant use of antidepressants, oral anticoagulants raises bleeding risk in AF patients
Jairia Dela Cruz, 14 Apr 2024
Patients with atrial fibrillation (AF) who take oral anticoagulants (OACs) and selective serotonin reuptake inhibitors (SSRIs) at the same time appear to have a higher likelihood of major bleeding.
Psilocybin for depression, anxiety holds manageable safety profile
13 Apr 2024
In the treatment of individuals with depression and anxiety, therapeutic single-dose psilocybin appears to be tolerable, with acute adverse effects that are resolved within 48 hours, according to the results of a meta-analyses.
sleepy girl
Kanas Chan, 11 Apr 2024
Excessive daytime sleepiness (EDS) is a risk factor for behavioural and emotional issues in children with obstructive sleep apnoea (OSA), researchers from the Chinese University of Hong Kong (CUHK) have shown.
Special Reports
Nicorette® QuickMist Launch Symposium
19 Jan 2024
During the launch of Nicorette® QuickMist at the Kuala Lumpur Nicotine Addiction International Conference (KLNAC) 2023, a panel of distinguished experts led the discussion on the role of Nicotine Replacement Therapy (NRT) on smoking cessation management. The panel comprised of notable experts, including Professor Chris Bullen (New Zealand), Associate Professor Dr Amer Siddiq bin Amer Nordin (Malaysia), Dr Philip Tønnesen (Denmark) and Professor Philip Eng (Singapore).
Long COVID: What we have learned so far
Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

Conference Reports
Young cyberbullying victims at heightened risk of self-harm
Jairia Dela Cruz, 24 May 2021
For children, being at the receiving end of online bullying makes them 12 times more susceptible to suicidal thoughts and actions, with the risk exacerbated by increased use of social media, as shown in the results of a meta-analysis presented at the virtual American Psychiatric Association (APA) 2021 Annual Meeting.
Bright light therapy at midday: Does it help in bipolar depression?
Elvira Manzano, 07 May 2021
Bright light therapy done at midday may be an effective and affordable adjunct to antimanic medication in patients with bipolar depression (BD), according to an expert who presented at APA 2021. This brings renewed attention to this natural, somatic treatment primarily used for seasonal depression.
Anxiety in MCI may lead to Alzheimer’s disease
Roshini Claire Anthony, 01 Jan 2021

Anxiety symptoms in patients with mild cognitive impairment (MCI) may increase their risk of developing Alzheimer’s disease, according to a study presented at the Radiological Society of North America annual meeting (RSNA 2020).